|
|
||||||||
J Thorac Cardiovasc Surg 1998;115:623-630
© 1998 Mosby, Inc.
CARDIAC AND PULMONARY REPLACEMENT |
Sponsor:
From the Departments of Surgerya and Medicine and Biochemistry,b Duke University Medical Center, and Howard Hughes Medical Institute,c Durham, N.C.
Read at the Seventy-seventh Annual Meeting of The American Associationfor Thoracic Surgery, Washington, D.C., May 4-7, 1997.
Received for publication May 7, 1997; revisions requested July 15, 1997; revisions received Sept. 29, 1997; accepted for publication Sept. 30, 1997 Address for reprints: Alan P. Kypson, MD, Box 3490, DukeUniversity Medical Center, Durham, NC 27710.
Abstract
Objective: The ability to transfer genes to adult myocardium may have therapeutic implications for cardiac transplantation. We investigated the feasibility of adenovirus-mediated transfer of marker genes LacZ and Luciferase, as well as the potentially therapeutic gene of the human ß2-adrenergic receptor in a rat heterotopic heart transplant model.
Methods: Donor hearts were flushed with 1012 total viral particles of one of three transgenes. Hearts were harvested at various time points after transplantation. LacZ-treated hearts were assessed by histologic staining and Luciferase-treated hearts were assayed for specific luminescence activity. Hearts treated with ß2-adrenergic receptor underwent radioligand binding assays and immunohistochemistry with the use of an antibody specific for the human ß2-adrenergic receptor.
Results: LacZ hearts revealed diffuse myocyte staining as opposed to none within controls at 5 days. Luciferase hearts demonstrated a mean activity of 970,000 ± 220,000 arbitrary light units versus 500 ± 200 for the controls (p = 0.001). Total ß2-adrenergic receptor densities (fmol/mg membrane protein) for hearts that received the ß2-adrenergic receptor transgene at 3, 5, 7, 10, and 14 days after infection were as follows: right ventricle, 488.5 ± 126.8, 519.4 ± 81.8,* 477.1 ± 51.8,* 183.0 ± 6.5,* and 82.7 ± 19.1; left ventricle, 511.0 ± 167.6, 1206.4 ± 321.8,* 525.3 ± 188.7, 183.5 ± 18.6,* and 75.9 ± 15.2 (*p < 0.05 vs control value of 75.6 ± 6.4). Immunohistochemical analysis revealed diffuse staining of varying intensity within myocardial sarcolemmal membranes.
Conclusions: We conclude that global overexpression of different transgenes is possible during cardiac transplantation and, ultimately, adenovirus-mediated gene transfer may provide a unique opportunity for genetic manipulation of the donor organ, potentially enhancing its function.
This article has been cited by other articles:
![]() |
A. Nakamura, R. Niimi, and Y. Yanagawa Protection from sepsis-induced acute renal failure by adenoviral-mediated gene transfer of {beta}2-adrenoceptor Nephrol. Dial. Transplant., November 3, 2009; (2009) gfp561v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Pandalai, J. M. Lyons, J. Y. Duffy, K. M. McLean, C. J. Wagner, W. H. Merrill, J. M. Pearl, and S. A. Akhter Role of the {beta}-adrenergic receptor kinase in myocardial dysfunction after brain death J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Deng, S. Szabo, T. Khomenko, M. R. Jadus, and M. Yoshida Gene Therapy with Adenoviral Plasmids or Naked DNA of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Accelerates Healing of Duodenal Ulcer in Rats J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 982 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sasse, Z. Ding, M. Wallich, A. Godecke, and J. Schrader Vascular transfer of adenovirus is augmented by nitric oxide in the rat heart Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1362 - H1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakamura, A. Imaizumi, Y. Yanagawa, T. Kohsaka, and E. J. Johns {beta}2-Adrenoceptor Activation Attenuates Endotoxin-Induced Acute Renal Failure J. Am. Soc. Nephrol., February 1, 2004; 15(2): 316 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Tevaearai, A. D. Eckhart, K. F. Shotwell, K. Wilson, and W. J. Koch Ventricular Dysfunction After Cardioplegic Arrest Is Improved After Myocardial Gene Transfer of a {beta}-Adrenergic Receptor Kinase Inhibitor Circulation, October 23, 2001; 104(17): 2069 - 2074. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Davidson, J. M. Jones, S. M. Emani, K. H. Wilson, J. Jaggers, W. J. Koch, and C. A. Milano Cardiac Gene Delivery With Cardiopulmonary Bypass Circulation, July 10, 2001; 104(2): 131 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Shah, D. C. White, O. Tai, J. A. Hata, K. H. Wilson, A. Pippen, A. P. Kypson, D. D. Glower, R. J. Lefkowitz, and W. J. Koch Adenovirus-mediated genetic manipulation of the myocardial {beta}-adrenergic signaling system in transplanted hearts J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 581 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lehnart, P. M. L. Janssen, W. M. Franz, J. K. Donahue, J. H. Lawrence, E. Marban, J. Prestle, and G. Hasenfuss Preservation of myocardial function after adenoviral gene transfer in isolated myocardium Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H986 - H991. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pellegrini, A. Jeppsson, C. B. Taner, T. O’Brien, V. M. Miller, H. D. Tazelaar, and C. G. A. McGregor HIGHLY EFFICIENT EX VIVO GENE TRANSFER TO THE TRANSPLANTED HEART BY MEANS OF HYPOTHERMIC PERFUSION WITH A LOW DOSE OF ADENOVIRAL VECTOR J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Shah, R. E. Lilly, A. P. Kypson, O. Tai, J. A. Hata, A. Pippen, S. C. Silvestry, R. J. Lefkowitz, D. D. Glower, and W. J. Koch Intracoronary Adenovirus-Mediated Delivery and Overexpression of the {beta}2-Adrenergic Receptor in the Heart : Prospects for Molecular Ventricular Assistance Circulation, February 1, 2000; 101(4): 408 - 414. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |